Top Analyst Upgrades and Downgrades for Tuesday
Investors and traders are usually on the lookout for new research ideas that will generate higher income or more profits. 24/7 Wall St. reviews many analyst research calls from Wall Street and from boutique firms to find great ideas in value stocks, growth stocks and dividend stocks. Some are stocks to buy, while some ideas are even stocks to sell. These are some of the top analyst upgrades, downgrades and initiations seen from select Wall Street research calls this Tuesday.
Charles River Labs International Inc. (NYSE: CRL) was downgraded to Sell from an already cautious Neutral with a lower $38 price target at Goldman Sachs.
Comerica Inc. (NYSE: CMA) was downgraded to Underperform from Market Perform with a $34 to $37 valuation at Wells Fargo.
Flir Systems Inc. (NASDAQ: FLIR) was upgraded to Strong Buy from Market Perform with a new $33 price target at Raymond James.
Genomic Health Inc. (NASDAQ: GHDX) was downgraded to Neutral from Buy at BofA/Merrill Lynch.
HSBC Holdings PLC (NYSE: HBC) was upgraded to Buy from Neutral at Citigroup.
Intuitive Surgical Inc. (NASDAQ: ISRG) was started as Outperform at Wedbush Securities.
Palo Alto Networks Inc. (NYSE: PANW) was maintained as Buy but removed from the prized Conviction Buy List at Goldman Sachs.
Toronto-Dominion Bank (NYSE: TD) downgraded to Equal Weight from Overweight at Barclays.
T-Mobile US Inc. (NYSE: TMUS) was started as Hold at Canaccord Genuity.
Wisdom Tree Investments (NASDAQ: WETF) was downgraded to Neutral from Buy at Citigroup.
The Williams siblings took a downgrade by Goldman Sachs: Williams Partners L.P. (NYSE: WPZ) was downgraded to Neutral from Buy and Williams Companies Inc. (NYSE: WMB) was maintained as Buy but removed from the prized Conviction Buy List.
Deutsche Bank has its Tech 8 list of stocks to buy in technology with dividends and growth.
UBS listed its Q-GARP list for quality growth stocks at a reasonable price.